Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-25-042855

CEO sold 6,276 shares at $2.98 ($18,721)

From the SEC's structured data for this filing

Trades in this filing

Shah Gaurav · CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-11-18 Sale : show line 1 in the form −6,276 $2.98 $18,721 778,296 D
Open-market sales · 6,276 sh · avg $2.98 · $18,721
Loading xslF345X05/form4.xml…